Induction therapy with PD-1 antibody combined with platinum-based doublet chemotherapy for locally-advanced non-small cell lung cancer: A randomised controlled, open-label, phase 2 trial

被引：0

作者：

Wang, Suyu ^{[1
]}

Zhang, Peng ^{[1
]}

机构：

[1] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Thorac Surg, Shanghai, Peoples R China

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8044

引用

页数：1

共 50 条

[41] Endostatin Combined with Platinum-Based Chemo-radiotherapy for Advanced Non-small Cell Lung Cancer
Xuan Jiang
Wei Guan
Mengxia Li
Wei Liang
Yi Qing
Nan Dai
Shiheng Zhang
Yi Deng
Hao Meng
Yuxin Yang
Zhaoyang Zhong
Cell Biochemistry and Biophysics, 2015, 71 : 571 - 577
[42] Toripalimab combined with concurrent platinum-based Chemoradiotherapy in patients with locally advanced cervical Cancer: an open-label, single-arm, phase II trial
Chen, Jie
Li, Chen
Cao, Yuanjie
Zhu, Li
Zhang, Bailin
You, Jinqiang
Hou, Hailing
Wang, Jing
Yuan, Zhiyong
BMC CANCER, 2022, 22 (01)
[43] Toripalimab combined with concurrent platinum-based Chemoradiotherapy in patients with locally advanced cervical Cancer: an open-label, single-arm, phase II trial
Jie Chen
Chen Li
Yuanjie Cao
Li Zhu
Bailin Zhang
Jinqiang You
Hailing Hou
Jing Wang
Zhiyong Yuan
BMC Cancer, 22
[44] Phase II study of gemcitabine-cisplatin-paclitaxel triplet as induction chemotherapy in inoperable, locally-advanced non-small cell lung cancer
Cappuzzo, F
De Marinis, F
Nelli, F
Calandri, C
Maestri, A
Benedetti, G
Migliorino, MR
Cortesi, E
Rastelli, F
Martelli, O
Andruccetti, M
Bartolini, S
Crinò, L
LUNG CANCER, 2003, 42 (03) : 355 - 361
[45] A randomized open-label study of gefitinib versus docetaxel in patients with advanced/metastatic non-small cell lung cancer (NSCLC) who have previously received platinum-based chemotherapy
Lee, D.
Kim, S.
Park, K.
Kim, J.
Lee, J.
Shin, S.
Kang, J.
Suh, C.
Ahn, M.
Ahn, J.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[46] A PHASE III TRIAL OF RH-ENDOSTATIN PLUS PLATINUM-BASED CHEMOTHERAPY VERSUS PLATINUM-BASED CHEMOTHERAPY IN PREVIOUSLY UNTREATED NON-SMALL CELL LUNG CANCER PATIENTS
Zhou, J.
Xiang, Y.
Gao, B.
Chen, W.
Li, Q.
Wan, H.
RESPIROLOGY, 2011, 16 : 147 - 147
[47] Circulating T-cell Immunosenescence in Patients with Advanced Non-small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based Chemotherapy
Ferrara, Roberto
Naigeon, Marie
Auclin, Edouard
Duchemann, Boris
Cassard, Lydie
Jouniaux, Jean-Mehdi
Boselli, Lisa
Grivel, Jonathan
Desnoyer, Aude
Mezquita, Laura
Texier, Matthieu
Caramella, Caroline
Hendriks, Lizza
Planchard, David
Remon, Jordi
Sangaletti, Sabina
Proto, Claudia
Garassino, Marina C.
Soria, Jean-Charles
Marabelle, Aurelien
Voisin, Anne-Laure
Farhane, Siham
Besse, Benjamin
Chaput, Nathalie
CLINICAL CANCER RESEARCH, 2021, 27 (02) : 492 - 503
[48] Erlotinib in progressive pretreated advanced non-small cell lung cancer (NSCLC): Results of a phase II open-label trial
Piantedosi, F., V
Gilli, M.
Caputo, F.
Casale, B.
Bianco, A.
Dericoloso, A.
Pontillo, A.
Crispino, C.
Giuliarini, G.
Hengheller, M.
Chianca, P.
ANNALS OF ONCOLOGY, 2007, 18 : 26 - 26
[49] Weekly paclitaxel for advanced non-small cell lung cancer patients not suitable for platinum-based therapy
Juan, O
Albert, A
Villarroya, T
Sánchez, R
Casan, R
Caranana, V
Campos, JM
Alberola, V
NEOPLASMA, 2003, 50 (03) : 204 - 209
[50] Phase III randomised trial of doxorubicin-based chemotherapy compared with platinum-based chemotherapy in small-cell lung cancer
Baka, S.
Califano, R.
Ferraldeschi, R.
Aschroft, L.
Thatcher, N.
Taylor, P.
Faivre-Finn, C.
Blackhall, F.
Lorigan, P.
BRITISH JOURNAL OF CANCER, 2008, 99 (03) : 442 - 447

← 1 2 3 4 5 →